Shi Gao Liu
Geen lopende functies
Vermogen: 5 M $ op 30-04-2024
Loopbaan van Shi Gao Liu
Eerdere bekende functies van Shi Gao Liu
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| SHANGHAI HENLIUS BIOTECH, INC. | Directeur/Bestuurslid | - | 30-09-2020 |
| Algemeen Directeur | 01-12-2009 | 30-09-2020 | |
| Oprichter | 01-12-2009 | 30-09-2020 | |
| President | 01-12-2009 | 19-02-2020 | |
Henlius Biopharmaceuticals, Inc.
 Henlius Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Henlius Biopharmaceuticals, Inc. focuses on development and commercialization of mAb-based therapeutics biosimilars and biobetter for malignant tumors and auto-immune diseases. The company was founded by Scott Liu and Paul Liu in 2009 and is headquartered in Fremont, CA. | Algemeen Directeur | 01-01-2009 | - |
| Oprichter | 01-01-2009 | - | |
| President | 01-01-2009 | - |
Opleiding van Shi Gao Liu
| Purdue University | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 3 |
| China | 2 |
Operationeel
| Chief Executive Officer | 2 |
| Founder | 2 |
| President | 2 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SHANGHAI HENLIUS BIOTECH, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Henlius Biopharmaceuticals, Inc.
Henlius Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Henlius Biopharmaceuticals, Inc. focuses on development and commercialization of mAb-based therapeutics biosimilars and biobetter for malignant tumors and auto-immune diseases. The company was founded by Scott Liu and Paul Liu in 2009 and is headquartered in Fremont, CA. | Health Technology |
- Beurs
- Insiders
- Shi Gao Liu
- Ervaring
